Precigen, Inc. (PGEN)

7.81 +0.21 (+2.76%) USD  |  NASDAQ  |  Oct 09, 16:00
7.81 0.00 (0.00%) After-Hours: 20:00
More

Precigen Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for PGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
September 25, 2026 --
September 21, 2026 --
August 06, 2026 --
August 05, 2026 --
July 27, 2026 --
June 12, 2026 --
June 01, 2026 --
May 28, 2026 --
May 15, 2026 --
May 14, 2026 --
March 26, 2026 --
November 14, 2025 --
November 07, 2025 --
September 25, 2025 --
August 24, 2025 --
Date Value
August 21, 2025 --
August 18, 2025 --
August 15, 2025 --
August 13, 2025 --
July 14, 2025 --
June 12, 2025 --
May 15, 2025 --
April 01, 2025 --
March 20, 2025 --
March 19, 2025 --
November 15, 2024 --
August 15, 2024 --
June 03, 2024 --
May 16, 2024 --
May 15, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Anika Therapeutics, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Repligen Corp. Upgrade
AC Immune SA Upgrade
Amgen, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade